GO-First: Real-world treatment patterns and effectiveness outcomes associated with gemtuzumab ozogamicin in first-line Acute Myeloid Leukaemia

05/12/2022
10/02/2026
EU PAS number:
EUPAS49268
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B1761038 GO-First Protocol 12Oct22 v1.0_FINAL

English (695.13 KB - PDF) View document
Updated protocol

B1761038_NON-INTERVENTIONAL STUDY PROTOCOL (Redacted)_V2_19OCT2023.pdf

First published: 09/02/2026
English (627.12 KB - PDF) View document

B1761038 Non Interventional Study Protocol Amendment 1_Version 2.0_19 October 2023.pdf

First published: 07/02/2025
English (455.06 KB - PDF) View document
Study results
Study report
Abstract of study report

B1761038_Non-Interventional Study Report (Fully signed_redacted)_V 1.0_16DEC2025.pdf

English (2.78 MB - PDF) View document
Other information